Nippon Life Global Investors Americas’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-880
Closed -$925K 112
2024
Q3
$925K Buy
880
+40
+5% +$42.1K 0.04% 95
2024
Q2
$883K Sell
840
-230
-21% -$242K 0.04% 89
2024
Q1
$1.03M Sell
1,070
-60
-5% -$57.7K 0.05% 87
2023
Q4
$992K Sell
1,130
-360
-24% -$316K 0.06% 110
2023
Q3
$1.23M Hold
1,490
0.08% 104
2023
Q2
$1.07M Hold
1,490
0.07% 109
2023
Q1
$1.22M Sell
1,490
-430
-22% -$353K 0.08% 105
2022
Q4
$1.39M Sell
1,920
-29,000
-94% -$20.9M 0.09% 102
2022
Q3
$21.3M Buy
30,920
+1,320
+4% +$909K 1.5% 20
2022
Q2
$17.5M Sell
29,600
-1,710
-5% -$1.01M 1.13% 27
2022
Q1
$21.9M Sell
31,310
-12,720
-29% -$8.88M 1.17% 22
2021
Q4
$27.8M Buy
44,030
+3,160
+8% +$2M 1.31% 15
2021
Q3
$24.7M Buy
40,870
+32,450
+385% +$19.6M 1.29% 16
2021
Q2
$4.7M Hold
8,420
0.23% 105
2021
Q1
$3.98M Hold
8,420
0.22% 107
2020
Q4
$4.07M Hold
8,420
0.24% 94
2020
Q3
$4.71M Hold
8,420
0.31% 80
2020
Q2
$5.25M Sell
8,420
-130
-2% -$81.1K 0.38% 68
2020
Q1
$4.18M Sell
8,550
-44,420
-84% -$21.7M 0.37% 71
2019
Q4
$19.9M Buy
52,970
+4,850
+10% +$1.82M 1.35% 18
2019
Q3
$13.3M Buy
48,120
+18,320
+61% +$5.08M 0.98% 32
2019
Q2
$9.33M Buy
29,800
+22,940
+334% +$7.18M 0.71% 50
2019
Q1
$2.82M Sell
6,860
-32,220
-82% -$13.2M 0.23% 107
2018
Q4
$14.6M Sell
39,080
-60
-0.2% -$22.4K 1.26% 25
2018
Q3
$15.8M Buy
39,140
+5,220
+15% +$2.11M 1.21% 27
2018
Q2
$11.7M Sell
33,920
-4,130
-11% -$1.42M 0.93% 36
2018
Q1
$13.1M Buy
38,050
+1,510
+4% +$520K 1.08% 28
2017
Q4
$13.7M Buy
36,540
+7,610
+26% +$2.86M 1.1% 30
2017
Q3
$12.9M Sell
28,930
-4,550
-14% -$2.03M 1.1% 32
2017
Q2
$16.4M Buy
33,480
+27,790
+488% +$13.6M 1.41% 17
2017
Q1
$2.21M Buy
+5,690
New +$2.21M 0.2% 113
2014
Q1
Sell
-5,430
Closed -$1.5M 167
2013
Q4
$1.5M Buy
+5,430
New +$1.5M 0.15% 130